PET scans to predict gene changes in lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether a special PET scan can help predict if lung cancer has a certain gene change (EGFR) that might affect treatment options. It aims to see if the scan can be used instead of a biopsy to find this gene change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (the most common type of lung cancer).
- You have already had a test to check for the EGFR gene change in your tumor.
- You are 18 years or older.
- Your blood sugar level is at least 200 mg/dl at the time of the PET scan.
- You have not had any cancer treatment before the gene test sample was taken.
- The PET scan and the gene test sample were taken within 1 month of each other.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This study compares two types of scans to see how well they find cancer spread in people newly diagnosed with non-small cell lung cancer. It may help doctors choose the best scan for staging.
This study uses a computer-generated PET scan from your CT scan to help doctors diagnose and plan treatment for non-small cell lung cancer more precisely. It is observational, meaning no new treatments are given—just extra imaging analysis.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This trial compares a new type of imaging scan (SPECT/CT) to the standard PET/CT scan to see if it can help diagnose and monitor lung cancer just as well. If you have lung cancer and are about to start treatment, you may be able to join to help test this new method.
This study uses a special PET-CT scan early in your treatment to see if immunotherapy (with or without chemotherapy) is working against your advanced lung cancer. The goal is to find out faster if the treatment is helping.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.